...
机译:通过降低苯并的亲脂性的苯并羟基磷酸酯尿酚蛋白调节剂减少Hepg2细胞毒性
Department of Chemistry University of Oxford Chemistry Research Laboratory;
Department of Chemistry University of Oxford Chemistry Research Laboratory;
Evoetec (U.K.) Ltd;
Department of Chemistry University of Oxford Chemistry Research Laboratory;
Evotec (France) SAS;
MDUK Oxford Neuromuscular Centre Department of Physiology Anatomy and Genetics University of Oxford;
MDUK Oxford Neuromuscular Centre Department of Physiology Anatomy and Genetics University of Oxford;
Department of Chemistry University of Oxford Chemistry Research Laboratory;
Summit Therapeutics plc;
Department of Chemistry University of Oxford Chemistry Research Laboratory;
Summit Therapeutics plc;
MDUK Oxford Neuromuscular Centre Department of Physiology Anatomy and Genetics University of Oxford;
Department of Chemistry University of Oxford Chemistry Research Laboratory;
Duchenne muscular dystrophy; utrophin upregulation; hepatotoxicity; phosphinate esters;
机译:ATM,ATR,DNA-PK抑制剂对人肝癌细胞系HepG2中苯并[a] re的细胞毒性和遗传毒性的调节作用
机译:RhoA的下调与HepG2细胞中亲脂性他汀类药物的细胞毒性作用有关。
机译:2-芳基苯[D]氨基磷酸盐膦酸酯作为尿素的第二代调节剂,用于治疗Duchenne肌营养不良症
机译:短链脂肪酸(外己酸)降低NF-KB反膜激活其抵押炎症诱导的炎症诱导的HepG2细胞中的载脂蛋白A-I转录
机译:击倒VDAC亚型降低线粒体膜电位并调节HepG2肝癌细胞中游离微管蛋白的作用。